Using the MR combined colocalization method, we identified several plasma proteins associated with breast cancer risk, notably CASP8 and DDX58, which are promising targets for developing screening biomarkers and therapeutic drugs for breast cancer. This evidence concerns the gene CASP8 and breast carcinoma.